Compare Newmont Corporation (NEM) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Newmont Corporation vs GeneDx Holdings Corp — how do they compare? Newmont Corporation trades at $92.41 (market cap $95.23B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Newmont Corporation is far larger — about 52.9× GeneDx Holdings Corp's market cap, and Newmont Corporation pays a 1.17% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| NEM | WGS | |
|---|---|---|
Market Cap | $95.23B | $1.80B |
Sector | Basic Materials | Technology |
52-Week High | $131.95 | $167.51 |
52-Week Low | $59.86 | $34.51 |
Enterprise Value | $91.98B | $1.80B |
Dividend Yield | 1.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
